Search for: "Saltonstall v. Saltonstall" Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2011, 8:37 am by FDABlog HPM
Saltonstall, president and CEO of the National Organization for Rare Disorders, applauded the PDUFA V proposal, saying that “[t]he document reflects a clear recognition that drugs for rare diseases warrant special consideration and special staff training.” [read post]